Compare CDMOs with oral solid dose manufacturing capabilities for tablets, capsules, and modified-release products. Filter by batch size, coating technology, and regulatory approvals.
373 companies listed
Tablets and capsules are the workhorse of pharma, roughly 60% of all drug products, so "oral solid dose CDMO" returns a crowded field. The differences that matter are technical, not marketing. Your API's flow and compressibility decide the granulation route: direct compression if it behaves, wet or dry granulation if it doesn't. A shop built for high-shear wet granulation isn't automatically the right home for a moisture-sensitive compound that needs roller compaction. Then there's scale. A CDMO that runs elegant 5,000-tablet clinical batches may not hold content uniformity at two million tablets a day. Heading toward extended- or delayed-release? Confirm the coating and multiparticulate expertise before you commit. Potent compound? Check the containment band (OEB) of the suite you'd actually run in. 373 CDMOs here list oral solid dose. Filter by batch size, coating technology, and regulatory market.
Oral solid dose (OSD) manufacturing is the highest-volume pharmaceutical manufacturing segment. Tablets and capsules account for approximately 60% of all drug products. The manufacturing process includes blending, granulation (wet or dry), compression or encapsulation, coating, and packaging. CDMOs range from small clinical-batch specialists to high-volume commercial manufacturers producing millions of units per day.
Modified-release technologies differentiate premium OSD CDMOs. Extended-release, delayed-release, and pulsatile-release formulations require specialized equipment and expertise in polymer coating, matrix systems, osmotic delivery, and multiparticulate approaches (pellets in capsules). These formulations improve patient compliance and can extend product lifecycle.
United States
UPM Pharmaceuticals is a U.S.-based CDMO specializing in late-stage commercial manufacturing of oral solid dose products. Operating from a 450,000 sq.ft. cGMP FDA-registered facility in Bristol, Tennessee, UPM is a family-owned company with 25+ years of experience. They handle DEA-controlled substances and provide services from technology transfer and scale-up through commercial manufacturing. Capabilities include formulation development, analytical development, coated tablet manufacturing, pharmaceutical serialization, aggregation, and full packaging and warehousing.
Italy
AbbVie Contract Manufacturing is an embedded CMO within AbbVie, providing third-party contract manufacturing services for over 40 years across 12 locations in the US and Europe. They offer services spanning antibody drug conjugates, aseptic fill/finish, biologics (mAbs and derivatives), custom API, eye care, hot melt extrusion, HPAPI, and oral solid dose manufacturing.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.